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ABSTRACT
Depression is a condition of no mood and loss of interest in any activity that can diminish a person’s thinking, conduct, tendencies, emotional state, 
and a sense of well-being. Although there is a conventional class of medication which have been beneficial in the treatment of depression, current 
studies have reported having side effects which can be minimized by the intervention of herbs and phytochemicals. Most of the studies have proven 
the various mechanisms and have started to research a very ground-breaking method by glancing the ancient treatmen. Where this new approach 
of using the herbs and phytochemicals has shown better results alone and in combination with conventional drugs which has shown lesser adverse 
effects. The practice of phytomedicine is an additional option for the treatment of depression. In the various segments of treating the depression, 
the mainstream can be a breakthrough including phytoconstituents. In this aspect, there are many contributions for the treatment of the depression 
acting to the neuronal level signaling and the phytoconstituents also have shown some basic mechanisms in the treatment of depression as that of the 
conventional medications following some primary hypothesis and signaling pathways and life interactions that effects the brain in either way to treat 
the depression in all sort of way. Clinical evidence is required to provide backing to the safety and effectiveness of herbs and phytochemicals alone or 
in combination with currently available drugs to overcome the reported side effects during the treatment of depression.
Keywords: Phytoconstituents, Interventional therapy, Phytomedicine.
INTRODUCTION
Depression is a condition of no mood and loss of interest to activity that 
can lessen a person’s thinking, conduct, tendencies, emotional state, and 
sense of well-being which has shown morbidity worldwide [1]. It has 
even reported as one of the prevailed psychiatric disorders which have 
been estimated as the second most significant contributor to neurological 
diseases and disability worldwide [2]. According to the World Health 
Organization Global Burden of Disease, depression has been predicted 
to become the second cause of long-term debility in 2020 and the 
primary cause by 2030 [2]. Depression is one of the highly prevailed 
neuropsychiatric disorders which has 40.5% of all disability attuned life 
years caused due to mental pathologies [3]. Major depressive disorder is a 
mental disease with clinical manifestations indulging anorexia, insomnia, 
loss of interest, and continuous sadness, where in contrast there may be 
hyperphagia, and motor agitation in addition. Depression can be managed 
by medications (pharmacological treatment), psychotherapy (cognitive 
behavioral therapy and interpersonal therapy), and electroconvulsive 
therapy. One potential method also involves the use of medicinal herbs 
and phytochemicals that provide therapeutic benefits with minimal 
adverse drug reaction [4]. The main cause or the origin of the depression 
can be from the gene level. It can be from the family twin or adoption. The 
genetic factors have the effect of 30–40% in depression. Other factors 
contribute to 60–70% to depression. Non-genetic factors are mainly 
socioeconomical causes which affect the population ranging from 15 to 
45 years including marital problems, divorce, lifetime trauma, low social 
support, interpersonal adversities, childhood sexual abuse, and loss 
of loved ones [5]. Depressogenic effects mainly can be gender specific 
with the high alterations in the average level such as men get affected by 
separation, work difficulties, and low income.
Meanwhile, women get affected by severe illness or death. The causes are 
many whereas the symptoms will be specific [6]. The sensory nervous system 
mainly senses various responses from the environment such as death, social 
stress, and retort to injuries in the human body, and then the sequenced 
information is carried out by the emotional circuits in the brain [7]. Since 
then there is no proper information regarding neuronal loops possessing 
the pathophysiology of the brain in depression (Table 1), the effort is made 
to note the significant hypothesis and some regions on depression [8]. The 
brain of a human was subjected to many types of research to have various 
alterations in the hippocampus, amygdala, striatum, prefrontal cortex, and 
cingulate cortex and many more, these irregularities in the brain were seen 
in a depressed patient during autopsy [9].
Types Depression [10]
Persistent depression
It is the mood that lasts for couple of years maybe two or three. A 
patient diagnosed with this depression have various symptoms with 
long term effects on behaviour
Postnatal depression
After getting a baby some women will get this type of depression. It 
is also called   “Baby Blues”. It is comparatively a lite depression and 
anxiety that clears within two weeks after delivery.
Bipolar depression
It includes the extremely low moods and euphoric or irritable conditions 
hence it is called It includes the extremely low moods and euphoric or 
irritable conditions hence it is called Maniac depression.
Seasonal effective disorder
It is also known to be “winter depression”. Usually occurs during 
winter season due to less light. It is mainly occurred with weight gain, 
increased sleep, and social withdrawal.
Medicinal herbs and phytochemicals used in depression
There are so many categories of conventional antidepressants used 
against depression such as Tri-cyclic antidepressants, monoamine 
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oxidase (MAO) inhibitor, and second-generation antidepressants. The 
MAO inhibitor block serotonin transporter (SERT), norepinephrine, 
which enhances their synaptic levels where it shows improvement 
neurotransmission. Monoamine inhibitors consist of tranylcypromine, 
phenelzine, isocarboxazid, and moclobemide are given as first-line 
therapy [30]. These inhibitors block norepinephrine and SERTs which 
shows enhancement of their level and increase in transmission. These 
chemicals increase the activity of neurotransmission [31].
Then, the second-generation antidepressants comprise serotonin-
norepinephrine reuptake inhibitors norepinephrine reuptake 
inhibitors, the selective serotonin reuptake inhibitors. Although 
there is so much of advancement in the field of medicine, there is a 
drawback in the treatment of depression, and there is a failure to 
remission of the disease [32,33]. Moreover, there are still cases like so 
many; adverse events have been causing for the patients from various 
types of the system like refractory responsiveness. There are so many 
adverse effects caused by these drugs such as tachycardia, tremor, 
sedation, insomnia, serotonin syndrome, anxiety, diaphoresis, postural 
hypotension blurred vision, Parkinson, and others [34,35].
All this research envisaged have seen alterations in the accumulative 
up gradation in the treatment with high adverse effects. Phytomedicine 
and medicinal herbs are one of the oldest ways of approach, but due to 
the fast medicine, the system has got buckled. However, now in recent 
days due to a higher number of adverse effects, this system of approach 
has got more importance due to less adverse effects and potent action 
as that of conventional antidepressants [36,37].
Medicinal herbs used in the treatment of depression
Herbs are one of the basic sources of medication used in ancient 
medicine. It is gaining one of the main prominences in the treatment 
of depression. Moreover, many studies have shown that there 
was an improvement in depression with the treatment of herbal 
medication. Some medicinal herbs have shown the effects as that of 
the antidepressants lately. The psychopharmacological actions against 
the nervous system by the medicinal herbs also have the same effects 
as that of the antidepressants which help in regulating the serotonin, 
dopamine, and noradrenaline reuptake, where it also helps in the 
MAO inhibition and modulation of neuroendocrine system along with 
hypothalamic-pituitary-adrenal (HPA) axis [38], there are some of the 
herbal medication which has been listed below and can be used in the 
treatment of depression.
Green tea
Camellia sinensis is commonly known as green tea. Where it is a herb 
generally known for its antioxidant property. The main bioactive 
constituents of green tea are caffeine, Theanine, xanthine, proteic, 
and nonproteinous amino acids and polyphenols where xanthine is a 
nonselective inhibitor of A2A and A receptors, which assists in performing 
the reduction of the excitatory neurotransmitter release and inflammatory 
responses and apoptosis which are some of the cause of depression [39].
Theanine is one of the main bioactive constituent that has shown higher 
antioxidant property and excellent antinflamatory action. Where it 
has shown excellent results in treatment with the synergistic action 
of theanine and caffeine with the elevated component polyphenols, 
the other main components present in the green tea are catechins, 
epicatechins, and epicatechins 5-gallate epigallocatechins [40].
The brain is vulnerable to various kinds of diseases like oxidative stress 
which is caused mainly due to the high amount of intake of oxygen free 
radicles in the neurons, which mainly serves as a prominent cause for 
the depressive-like behavior. In addition to this, there will be a release 
of excitatory neurons and dysfunction of mitochondria and drastic 
changes in the blood–brain barrier. Where the cause as the research says 
the gamma-aminobutyric acid (GABA) A receptor dysfunction, all these 
abruptions in the brain may be treated by the green tea with its various 
components such as polyphenols, catechins, and caffeine by elevating 
the serum level of corticosterone and by regulating the HPA axis with its 
action by decreasing the oxidative stress by its antioxidant property [41].
St. John’s wort
Hypericum perforatum is also called St. John’s wort. In the present 
studies, it has shown that medicinal form of St. John’s wort comprises 
various leaves and flowering tops with the components of xanthones, 
naphthodianthrones, flavonoids, phloroglucinols (hyperforin), and 
hypericin. Latest researches have shown that H. perforatum has shown 
the improvement in depression like that of typical antidepressants 
selective serotonin reuptake inhibitors, and tricyclic antidepressants [42]. 
H. perforatum can inhibit the monoamine neurotransmitters such as 
5-hydroxytryptamine (5-HT), noradrenaline, and dopamine where it 
increases the concentration of other monoamines and serotonin in various 
extracellular space in a brain such as thalamus, amygdala, hippocampus, 
and the prefrontal cortex [43]. Upregulation of the 5-HT receptors is one 
of the primary functions of the H. perforatum which, in turn, has the effects 
of upregulation of the neurons, in turn, leading into a factor of dopamine 
reducing the background firing in the neurons. This herb also have its 
effects in the upregulation of the factor in 5-HTAA receptors as that of the 
SSRIs; it also has its effects in blocking the binding of GABA3, which has 
the effects in the reduced storage capacity of the central nervous system 
(CNS). H. perforatum has its effects in N-methyl-D-aspartate receptors 
(NMDARs) which has its necessary action as that of the nootropics [44].
Many studies have shown that the main constituents of this herb which 
are hypericum and hyperforin have a major effect in the neuronal 
transmission like; hypericum has its structure similar to that of MAO 
inhibitors which suppress the release of the interleukin 6, where 
interleukin 6 is one of the substances that help in the inflection of the 
cortisol release, reuptake inhibition of dopamine, norepinephrine, 
serotonin, and gamma-aminobutyric acid by hyperforin [41].
Lavender
Lavender is a herbaceous plant known as Lavandula angustifolia, with the 
recent researches it has shown that lavender in aromatherapy has shown 
Table 1: Pathophysiology of Depression
Hypothesis Theory stated
Neuronal atrophy Reduction in the flow of blood, metabolism of glucose, and hence in the parts of the hippocampus and prefrontal 
cortex the volume will be reduced [10]
BDNF role Reduction in the level of protein primarily in the dentate gyrus of the hippocampus and BDNF mRNA in the neuronal 
junctions [11]
Variability in gene Proper research has been made from twin studies that 30–40% of depression will be from variations in the genes [12]
Stress hormones and 
cytokines
Increased functional activity of MG and reduced limbic GR receptor function system suggests an imbalance in MG/GR 
ratio in the stress-related condition that leads to depressive disorder [13]
Role of monoamines Exhaustion of neurotransmitters such as noradrenaline serotonin, or dopamine in the central nervous system and 
improper functioning of the central noradrenergic system [14]
Neurotrophic hypothesis The decrease in the hippocampal BDNF level [15]
Circadian rhythms Damage in the sleep-wake directive in depressed patients can be daytime variations in psychomotor activity and mood 
fluctuations in the convenience of memories of positive and negative experiences [16]
GR: Glucocorticoid, BDNF: Brain-derived neurotrophic factor
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outstanding results as a hypnotic and mild sedative, and the women who 
have undergone delivery were shown positive response toward their 
infants and have overcome postpartum depression. The active ingredients 
of lavender that is linalool and linalyl acetate which has shown rapid 
absorption in the plasma peak have been proven in the recent study [45]. 
Most of the therapy given by lavender is shown to be aromatherapy where it 
has even shown its effects on the respiration during the sleep has improved 
the quality of sleep by suppressing the cause of insomnia. Where the 
studies even have shown the significant effects on the increased 2nd stage 
of the sleep. Where the sleep was successfully induced with the elevation in 
the mood, and there were no side effects reported, which indirectly gives a 
betterment of depression by modulating the circadian rhythm[46].
The essential oil in L. angustifolia has a significant effect in the CNS with 
the popular target areas such as GABA A, SERT, MAO-A, and NMDARs; 
recent studies have shown that lavender even exhibits its action on 
the dose-dependent characteristics with the significant effects on 
glutamate NMDARs by showing its affinity. The lavender possesses the 
other major component that is linalool which was even bound to SERT, 
the primary context of the whole theme is due to SERT inhibition and 
NMDAR antagonism (Table 2) [47].
Ginseng
Panax ginseng is a botanical name of ginseng and is mainly used to 
treat clinically. It was one the best medicine in past years, Where in 
recent days, several pieces of research have confirmed that ginseng has 
shown antidepressant-like activity with its component ginsenosides 
in experimental animal models. There are many causative factors for 
the induction of the depression like Glial cells aggregation  along with 
blocking the neuronal cells, but the recent studies have shown that glial 
cells have astrocytes which show an major role in the pathogenesis of 
depression [48]. Where ginseng effectively regulates the response in the 
immune system and it has also helped in maintaining the homeostasis. 
In addition to the psychological diseases, it has shown various effects 
in treating depressive-like disorders. Recent studies have shown that 
ginseng is involved in the treatment of the HPA axis, like the HPA 
axis and also involved in the controlling of the hormones which are 
beneficial for the further process. The cortisol is mainly produced and 
regulated in the control center of the brain that is HPA axis and also 
regulated by the sympathetic nervous system [49].
The HPA axis plays an essential role in regulating all the endocrine glands 
related to the CNS, where ginseng regulates the chronic inflammation 
through the HPA axis to inhibit various disorders, mainly depression. 
However, there is no reference as such for the potential biomarking of 
the HPA axis by ginseng since the studies are still on progress. However, 
the ginseng has demonstrated various levels of the efficacy in many 
levels of the process. The neuroprotective effect of the ginseng has 
various effects enhanced ameliorate anxiety with depression [50].
Table 2: Novel perspective of various mechanisms in depression:
Mechanisms Theory
Ketamine and other non-selective 
NMDAR antagonists
Dysfunction of the glutamatergic system was a profound action on the depression, where the NMDARs are 
a grounding system for the treatment of depression [17]. Ketamine one of the rapid NMDAR antagonists 
shown to have a rapid action on the depression
Ketamine acts by elevating the presynaptic glutamate release, ensuing instigation of Akt and an extracellular 
signal associated with kinase (extracellular signal-regulated kinase) signaling, which, in turn, stimulates 
mTOR signaling [18]. The activation of mTOR signaling increases the downstream synaptic protein synthesis 
by phosphorylation of kinase and inhibiting the binding protein
Hence, ketamine modulates mTOR signaling by increasing BDNF [19]
Selective NMDAR 
subtype 2B (NR2B) antagonists
Among all the NMDAR subtypes, NMDAR subtype 2B is of the efficient receptor that expresses in the 
forebrain and is associated with NMDA neurotoxicity genetic obliteration of NR2B from the principal of 
cortical neurons with the suppression of the behavior by elevating the mTOR action in the synaptic protein 
synthesis. Where traxoprodil is a selective NR2B antagonist [20,21]. All these studies were conducted on 
experimental mouse models
NMDA Partial agonists NMDA partial agonists are usually comprehended as NMDAR modulators because they have agonist action in 
lesser doses. Hence, NMDA agonists are considered as latent antidepressants[22]
D-cycloserine is one of the NMDA partial agonists where diminished long-term potentiation in the neural cell 
connexion in the molecule inadequate mice model[23]
Where D-cycloserine increases the expression of Arc protein, which was associated with memory 
amalgamation [23]
NK 1 antagonists NK 1 antagonists is a neuromodulator and a neurotransmitter which acts on NK 1 receptors
Where the initial excitement about conjectural antidepressant properties of NK-1 which was decreased in a 
clinical trial study [23]
Orexin signaling activation Orexin signaling is a well-known function which regulates the consolidation of stimulation of metabolism 
regulation, regular food intake, and mediating responses
Although orexin lack is not a sole reason for depression, many preclinical studies have been made for the 
symptoms[24]
Ghrelin is a peptide hormone produced by ghrelin cells in the gastrointestinal tract and functions a 
neuropeptide in the central nervous system where Ghrelin plays a significant role in regulating the 
distribution rate, whereby inducing effective feeding response and the use of energy[25] in response of 
energy shortage, orexin neuron will induce an active nourishing reaction by triggering growth hormone 
which secretes ghrelin receptors that exits in the central nervous system[26]
Ghrelin which activates the neurons via c-FOS expression in the orexin cells, by the polymorphism detected 
the number of depressive cases was treated with ghrelin administration, which has shown an elevation in 
the mood of the patient [27]
Transcranial magnetic stimulation Although electroconvulsive therapy has cognitive shortfalls, the stimulation of the safer brain has been formed 
by tedious TMS, which was approved by the FDA for the treatment of depression [28]
This therapy stimulates the neurogenesis, and in some studies, it was proved that TMS modulates the amygdala 
by increasing neurotransmitters such as serotonin and dopamine [29]
mTOR: Mammalian target of rapamycin, BDNF: Brain-derived neurotrophic factor, NMDAR: N-methyl-D-aspartate receptor, Arc: Activity-regulated 
cytoskeletal, NK 1: Neurokinin 1, TMS: Transcranial magnetic stimulation 
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Lemon balm
Lemon balm is also called Melissa officinalis it is an ancient drug, which 
was very reliable during the curative treatment from the ancient times. 
M. officinalis has shown high phenolic content and has a vigorous 
property of antioxidant. Lemon balm has even demonstrated the 
antioxidant property and immune modulating property, which has 
a property of autoxidation and EDTA-mediated oxidation by linoleic 
acid [51]. The free radicle scavenging property of the lemon balm is 
very known action as an antioxidant and its significant effect in the 
neurotransmitter due to radicles rush in the presynaptic junction. 
There are many streams of pathways describing the uses of lemon 
balm, where the concentration variations of monoamines like serotonin 
(5-HT) in the CNS. The selective serotonin in the CNS was checked by 
the antioxidant property [52].
Lemon balm is a tranquilizing antioxidant. It was shown that it has a 
benefit of exhaustion in the nervous tissue. M. officinalis herb generally 
acts on the brain tissue with its property of blood–brain barrier crossing 
capacity. It generally falls to the category of green tea. Furthermore, it 
has proven to show a synergistic effect [53].
Cocoa
Cocoa is obtained from Theobroma cacao where many types of research 
have proven that cacao is a polyphenolic compound and was proven 
to have a calming effect, due to its affinity for adenosine and GABA 
receptors. There are many pieces of evidence stating that cocoa affects 
cognitive performance and an increase in cerebral blood flow. Cocoa-
derived products have discovered to have a high level of flavonoids and 
to have antioxidant property [54]. Where many studies have proven that 
phenolic cocoa extract was shown to have a protective effect on neurons 
and has even revealed an increase in neurotransmitters including the 
rise in the serotonin levelse. The ingestion of this carbohydrate may 
cause an increase in serotonin and neurotransmitter has stated to have 
a significant role in the psychopharmaceutical target [55]. Some studies 
have stated that ingestion of carbohydrates with some 6% of protein 
there was an increase in the serotonin synthesis that may be due to the 
protein which has relatively less tryptophan than any amino acids with 
a very high range of blood tryptophan induced secretion of insulin.
As the research says, chocolate composition is not the same where 
there is no certainty. However, many studies have hypothesized that 
chocolate is rich in sugar but less protein that has favored the serotonin 
synthesis [56].
Ashwagandha
Withania somnifera is also called Ashwagandha where it is considered 
as an adaptive and was mainly used to diminish and accelerate the 
hypothalamic-pituitary thyroid neuroendocrine axis where that 
has been associated with the pathogenesis of major depression. 
Ashwagandha is shown as “adaptogen” which means that it has a 
magnificent antioxidant property, and referred to as neuroprotective, 
anti-inflammatory and has a perfect memory enhancing property [56]. 
Withania somnifera crosses the blood brain barrier. Where many 
clinical studies have been proven that W. somnifera can withstand all 
the stressors and help to regulate the psychological process, by acting 
on GABA with receptor binding receptor in many animal models [57].
W. somnifera has also been used in the treatment of cerebrospinal 
fluid (CSF) GABA level elevation and the correlation between GABA-
CSF concentration and clinical status. This has led to the preliminary 
indication disconcerted GABAergic transmission and GABA-mimetic 
agents in an animal model [58].
Roseroot
Rhodiola rosea known as the rose root is the phytomedicine which has an 
adaptogenic property and is effective in treating moderate depression. 
The range of depressive disorder that has a major level of biochemical 
imbalances of monoamine like epinephrine, norepinephrine, and 
serotonin [59]. Although psychopharmaceutical drugs appear to have 
an essential role in the treatment of depression, the current study status 
has an extent of research. The standardized root extracts serotonin-5, 
including the neurotransmitter levels and in the CNS [60].
R. rosea is system-stimulating serotonin-5 and the nervous treatment 
system with the process of oxidative deamination and peripheral tissue. 
The level of MAOA inhibitors has shown to be active and often associated 
with pharmacological treatment [61]. 
Phytochemicals used against depression
L-theanine
L-theanine is an amino acid obtained from C. sinensis which is also 
known as green tea. Where L-theanine emerges to be a nonproteinous 
amino acid and has a fantastic property of crossing the blood–brain 
barrier and proven to be elevated to the brain in a dose-dependent 
manner. Many preclinical studies on rats have been made to check 
the attenuation of hippocampal CA1 long-term potentiation after the 
exposure to the stress-induced suppression of recognition memory 
was rescued by L-theanine [62]. The cognitive dysfunction on the mice 
was found to be more effective by the treatment of L-theanine and its 
antidepressant effects. The antidepressant effect of L-theanine together 
with NMDARs has shown agonist action. In healthy humans, L-theanine 
has shown better effects in the reduction of anxiety and depression has 
been scored. L-theanine was proven to decrease the sympathetic nerve 
responses [63]. Many studies have proved that electroencephalogram 
studies have affected both the sites and α-wave including the influence 
prefrontal cortisol function, having the dominant effect on the cognitive 
impairment and process associated with the memory impairment [64].
In most of the studies, the mainstream of the depression was affected 
by the prefrontal cortex, and magnetic resonance spectroscopy has 
revealed that patients with the depressive disorder have the exhibited 
the increase in the level of glutamate in the hippocampus region. Where 
L-theanine is an amino acid shown exhibit the alterations and profiles 
through competitive inhibition of the transporters which, in turn, has 
influenced the transporters and neurotransmitter function [65].
Carvacrol
Carvacrol is an aromatic herb obtained from oregano and thyme. The 
carvacrol is a significant constituent seen in essential oils and aromatic 
plants. It has shown various properties on cognition and has a significant 
effect on the depression. Besides, it was proven to be the chemical 
flavonoid, and the safety index is yet to be proved. Many clinical studies 
have been done using carvacrol as it acts on estrous stage specific in the 
depressed women patient and it has exhibited its effect by serotonin 
and metabolite tissue content in the prefrontal cortex and nucleus 
acumens the involvement in the serotonergic system [66].
The carvacrol is a monoterpenoid phenol which, in turn, regulates 
the human ion channels and transient receptor potential and has a 
significant effect in the V3 and A1 potential causing the warmth. The 
carvacrol has a significant property of activation of the peroxisome 
proliferator-activated receptor and to subjugate the cyclooxygenase - 2 
mediated depression [67]. The carvacrol on the administration has 
proven to act on the dopaminergic brain pathways and rise in the 5-HT 
and dopamine ranges and prefrontal cortex [68].
Curcumin
Curcumin is obtained from Curcuma longa also known as turmeric. 
Where it has a mechanism of antidepressant activity and is inhibited 
by MAO A and B here the phytochemical has proven to show the 
elevation of neurotransmitter level in the brain. The antidepressant 
effects of curcumin have shown to represent the significant hypothesis 
of depression that is the cytokine hypothesis and monoamine 
hypothesis [69]. Where curcumin has shown the increase in the 
concentration of monoamine which is available to interact with the 
receptors and has shown the elevation similarly as that of the tricyclic 
antidepressants [70].
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The mechanism has even stated that curcumin is proven to show anti-
inflammatory activity as that of the hypothesis of cytokine, which has 
raised the crucial role in the development of the major depressive 
disorder. Besides, the curcumin has strongly inhibited the anti-
inflammatory cytokines like a nuclear factor that is kappa B and NLRP3 
inflammasome and interleukin-1B. Curcumin from the long back has 
proven to be a neuroprotective alongside conventional therapy in the 
trails [71]. Furthermore, the laboratory studies have been proven to 
exhibit the behavioral changes in the HPA axis and the brain-derived 
neurotrophic factor (BDNF). A new approach to the medical stream was 
found by treating the synthetic drug along the side of a natural herb 
or the phytochemical [72]. It was extensively started proving from the 
drug of curcumin, and the action proved to be synergistic. The large-
scale sequenced treatment alternatives to relieve depression and due 
potential have a chance of balancing the monoaminergic pathways and 
HPA axis disturbances [73].
Ferulic acid
Ferulic acid is an organic compound mainly found in seeds, leaves, 
and plant cell walls. The ferulic acid has been reported to have 
various neurotherapeutic effects concerning the ameliorative action 
on glutamate excitotoxicity along with apoptosis and high reactive 
oxygen species (ROS) level [74]. The enhancement of the indoleamine 
2,3-dioxygenase action in the brain resulting in the atypical shift of 
tryptophan metabolism near to kynurenine away from serotonin. 
Where the reduction in the brain levels explains the effectiveness 
of drugs and has to be elevated where ferulic acid has shown its 
action as an antidepressant [75]. The primary study was done that 
depressant patients tended to show the effects on the system by the 
overproduction of glucocorticoids has involved in the antioxidant 
defense and reduction and hyperactivation of NMDAR leading to cell 
death. Most of the treatment used in the treatment of depression will 
be through, a monoaminergic system [76].
The research has stated significant evidence that ferulic acid is a phenolic 
compound that is widely distributed in many species of plant, counting 
many grains, fruits, and vegetables which can reach the blood-brain 
barrier. Ferulic acid is a well-known antioxidant and a glutamate 
correspondent molecule that gives protection in contradiction of 
glutamatergic excitotoxicity which indicates an NMDAR antagonism 
effect [75].
Proanthocyanidin
Proanthocyanidin is an oligomeric and polymeric flavan-3-ol found 
in various plants including apple, cocoa, bean, grape, and tea [77]. 
The studies have proved that there will be overexpression of pro-
inflammatory cytokines in the hippocampus, prefrontal cortex, and 
amygdala were these are reversed by proanthocyanidin [78].
Proanthocyanidin is a protectant acts an antioxidant and also helps 
in the reduction of glutathione along with glutathione peroxidase, 
superoxide dismutase, and catalase enzyme in the liver [79,80]. Where 
proanthocyanidin has a property as a natural antioxidant and keeps ROS 
scavenging action. Proanthocyanidin has shown superior scavenging 
contrary to hydroxyl radicals and as compared to both Vitamin C and 
Vitamin E [81].
Resveratrol
Resveratrol is a natural phenol found in grapes and red wine. 
Resveratrol has an outstanding property of neuroprotective [82,83]. 
The resveratrol has a significant effect on the regulation of antioxidant 
effect by ameliorating the hyperactivity of the HPA axis, and resveratrol 
is also testified for the metabolism of the noradrenaline and serotonin 
and acts as another antidepressant. The mainstream of proving the 
action of resveratrol is by its BDNF modulation in the brain. It has been 
shown that the resveratrol has been occupied the dominant stream in 
acting as a neuroprotective agent with the huge ability to escalate the 
neurogenesis, with many other disorders in the brain. Resveratrol has 
also proven to show the action as the best sleep inducer with anti-aging 
property [48,84]. In addition to the system, monoaminergic and 
molecular markers are related to depression which has a complication 
with both hypothalamic-pituitary-thyroid axis and HPA axis [79,80].
In many studies, the resveratrol has proven to have an action on 5-HT 
and noradrenaline to restore the normal monoaminergic function and 
to produce the antidepressant activity by BDNF involved expression in 
the system [85].
CONCLUSION
From past centuries, the knowledge about the herbs has proven to be 
beneficial to humankind. The whole system was followed with a basic 
concept of curing the disease in the intensely passionate form of the 
way with the available resources around us. Now in a recent decade, 
there is an advancement wherein the system there is scope for the 
phytochemicals which is obtained from the different sources. All these 
herbs and phytochemicals above mentioned will come under various 
hypothesis and mechanisms of depression. Where there are some herbs 
like green tea where the photochemical like L-theanine is extracted, 
which, in turn, has a preferment with the elevation in the concentration 
of neurotransmitters or inhibition of the neuronal apoptosis.
As abridged here, the preclinical and clinical studies have proven the 
mechanism on which these drugs tend to act on the human brain to 
repose the depression and its symptoms. The primary cause of using 
the phytomedicinal herbs and chemicals is because it does not have the 
adverse effect as that of the counterfeit medicine used in the treatment 
of depression. The other cause of using the phytomedicine maybe it is 
pocket-friendly because of the whole system of costing much money 
for the conventional drugs to obtain it from the market which may 
be not be affordable by the ordinary people. Since the safety index is 
useful in treating the patients with phytomedicine, as these herbs and 
phytomedicine have shown positive results in a preclinical stage with 
both in vivo and in vitro. However, clinical studies are taken aback. While 
the efficacy and the potency of phytomedicine have to be supported by 
the clinical studies and the mechanisms of these drugs should be tamed 
well.
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